Alberto-Culver (ACV): Short: I am leery of anything tied to the consumer, especially personal beauty product, which is why I think shares of Alberto-Culver should be avoided going into this week’s earnings report. Alberto-Culver which operates in the personal healthcare products space could see a substantial decline in earnings this quarter, as weakness across all of their branded beauty care items.

American Express (AXP): Long: Trading right at its 52-week low of $15.50 or so, and down 70% for the year, shares of American Express could likely move into the $18-$19 range based on bottoming fundamentals and an extremely negative sentiment. Sporting the highest risk adjusted yield (4.7%) and the lowest net write-offs (4.3%) versus Citigroup, Capital One, J.P Morgan, and Discover card, American Express should be trading for a premium to the group---not at a discount. My guess, the stock works higher from here

Amgen (AMGN): Long: Amgen was hit particularly hard on Friday, as rumors surrounding a possible Pfizer (PFE) Wyeth (WYE) merger took some speculative winds out of Amgen’s sails. Even still, Amgen is the fastest growing large cap biotech company, with one of the deepest pipelines and largest current cash flows. I think the recent decline in the stock sets up well as a trading opportunity

EMC Corp (EMC): Long: With positive earnings from Apple (AAPL), and IBM (IBM), EMC, which already pre-announced quarterly earnings of 23 cents or 24 cents per share on sales of about $4 billion versus analyst estimates of 21 cents per share on $3.9 billion in revenue, could move higher

New York Community Bankcorp (NYB): Long: The one bank that actually rejected TARP capital form the government should be respected by investors—not hated, as near its 52-week low suggests. Recently, NYB’s CEO Joseph Ficalora hinted that NYB might surprise to the upside, saying “Recently, our spreads have been widening out

No Analysis added

No Analysis added

No Analysis added